These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2008 Feb 15; 57(6):144-8. PubMed ID: 18272956 [Abstract] [Full Text] [Related]
5. Pneumococcal conjugate vaccine for young children. Selman S, Hayes D, Perin LA, Hayes WS. Manag Care; 2000 Sep 15; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663 [Abstract] [Full Text] [Related]
6. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007. Hsu KK, Shea KM, Stevenson AE, Pelton SI, Massachusetts Department of Public Health. Pediatr Infect Dis J; 2010 Apr 15; 29(4):289-93. PubMed ID: 19935447 [Abstract] [Full Text] [Related]
7. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2010 Mar 12; 59(9):253-7. PubMed ID: 20224541 [Abstract] [Full Text] [Related]
8. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2007 Oct 19; 56(41):1077-80. PubMed ID: 17947966 [Abstract] [Full Text] [Related]
9. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL. Clin Infect Dis; 2008 Aug 15; 47(4):476-84. PubMed ID: 18627249 [Abstract] [Full Text] [Related]
10. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Isaacman DJ, McIntosh ED, Reinert RR. Int J Infect Dis; 2010 Mar 15; 14(3):e197-209. PubMed ID: 19700359 [Abstract] [Full Text] [Related]
11. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP. Pediatr Infect Dis J; 2007 Sep 15; 26(9):771-7. PubMed ID: 17721369 [Abstract] [Full Text] [Related]
12. Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2008 Oct 24; 57(42):1148-51. PubMed ID: 18946462 [Abstract] [Full Text] [Related]
13. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R. Clin Infect Dis; 2008 Jan 15; 46(2):174-82. PubMed ID: 18171247 [Abstract] [Full Text] [Related]
14. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America. Giglio N, Micone P, Gentile A. Vaccine; 2011 Sep 14; 29 Suppl 3():C35-42. PubMed ID: 21896351 [Abstract] [Full Text] [Related]
15. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics; 2010 Jul 14; 126(1):186-90. PubMed ID: 20498180 [Abstract] [Full Text] [Related]
16. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections. Zangeneh TT, Baracco G, Al-Tawfiq JA. Expert Rev Vaccines; 2011 Mar 14; 10(3):345-53. PubMed ID: 21434802 [Abstract] [Full Text] [Related]
18. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R, McCracken GH. Pediatr Infect Dis J; 2010 Apr 14; 29(4):294-300. PubMed ID: 19949357 [Abstract] [Full Text] [Related]
19. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, O'Brien KL. Clin Infect Dis; 2008 Oct 15; 47(8):989-96. PubMed ID: 18781875 [Abstract] [Full Text] [Related]
20. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW. Clin Infect Dis; 2009 Jul 15; 49(2):205-12. PubMed ID: 19508165 [Abstract] [Full Text] [Related] Page: [Next] [New Search]